Zenith Healthcare Limited (530665) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Zenith Healthcare Limited stock ₹1.88, price ₹3.20, that is 41.3% below the price, quality 52 out of 100. Rating: strongly overvalued. Calculated from audited financials with 8 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Zenith Healthcare Limited
530665 · BSEFar too expensive (fair value 41% below the price) and falling price, but solid company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range ₹2.42 – ₹11.20 · fair‑value band ₹1.88 – ₹2.82 · the ₹3.20 price screens above the ₹1.88 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 17, 2026.
Every Wednesday you see whether Zenith Healthcare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Zenith Healthcare Limited manufactures, sells, and exports pharmaceutical formulations in India. The company offers products in the form of tablets, capsules, oral liquids, and injections in various therapeutic areas. It also engages in the contract manufacturing of various dosage forms.
Show moreShow less
The company also supplies medicines to Cambodia, Myanmar, Papa New Guinea, Sri Lanka, Kenya, Nigeria, Gambia, Zambia, Namibia, Botswana, Armenia, Georgia, Uzbekistan, Paraguay, Bolivia, Venezuela, Guatemala, Barbados, Jamaica, Bahamas, Yemen, and Turkey.
Zenith Healthcare Limited was founded in 1994 and is based in Ahmedabad, India.
Stock analysis
Zenith Healthcare Limited (530665) currently trades at ₹3.20, while our model-based Fair Value estimate is ₹1.88, 41% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹1.88 per share, and 3 of the 7 models we run sit above the ₹3.20 price.
Bear case: the Earnings-Based group reads lowest at ₹1.88, and 4 of the 7 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹1.88 (bear) to ₹2.82 (bull), the price of ₹3.20 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 52/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Zenith Healthcare Limited reported revenue of ₹105M in FY2026 versus ₹224M in FY2022, a compound −17.2%/yr. Reported net income was ₹51.0K in FY2026, compounding −64.2%/yr from FY2022.
Key figures
Market cap ₹247M (≈ $2.6M) Micro · P/E ratio 30.1 · P/S ratio 1.69 · EPS (TTM) ₹0.1700 · Net margin 6.9% · Return on equity 15.7% · Return on assets (EBIT) −1.2% (5-year average) · Operating margin 6.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 18% below its 52-week high and 32% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −41%, 530665 screens richer than that median.
Fair Value models
All 8 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
530665 screens overvalued: fair value 41% below the price. Compare with Merck KGaA →
Compare Zenith Healthcare Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Dividend yield by industry
- EV/EBITDA by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $84.39 | $113.53 | +35% | vs 530665 |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs 530665 |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs 530665 |
| Haleon plc HLN | $9.20 | $8.47 | −8% | vs 530665 |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs 530665 |
| Galderma Group GALD | CHF 191.00 | CHF 112.46 | −41% | vs 530665 |
| Takeda Pharmaceutical Company TAK | $21.59 | $11.23 | −48% | vs 530665 |
| Teva Pharmaceutical Industries Limited TEVA | $42.57 | $20.74 | −51% | vs 530665 |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs 530665 |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs 530665 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Zenith Healthcare Limited (530665) overvalued or undervalued?
What is the fair value of 530665?
What is the quality score of 530665?
What is the price target for Zenith Healthcare Limited (530665)?
What is the Zenith Healthcare Limited stock forecast for 2026?
What is the revenue of Zenith Healthcare Limited (530665)?
What is the intrinsic value of Zenith Healthcare Limited (530665)?
Is Zenith Healthcare Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 530665?
How much is Zenith Healthcare Limited worth?
What do the bullish and bearish scenarios say about 530665?
What is the P/E ratio of 530665?
How solid is the balance sheet of Zenith Healthcare Limited (530665)?
How far is 530665 from its 52-week high?
Which stocks are comparable to Zenith Healthcare Limited?
Is Zenith Healthcare Limited stock attractive at the current price?
How is the fair value of 530665 calculated?
Is it still worth investing in stocks now?
What is the share price of Zenith Healthcare Limited (530665)?
What should I pay attention to with Zenith Healthcare Limited right now?
Key figures of Zenith Healthcare Limited
How large is the market capitalisation of Zenith Healthcare Limited (530665)?
What is the P/S ratio of Zenith Healthcare Limited (530665)?
What are the earnings per share of Zenith Healthcare Limited (530665)?
What is the net margin of Zenith Healthcare Limited (530665)?
What is the return on equity of Zenith Healthcare Limited (530665)?
What is the EBIT return on assets of Zenith Healthcare Limited (530665)?
What is the operating margin of Zenith Healthcare Limited (530665)?
How fast is revenue growing at Zenith Healthcare Limited (530665)?
How fast are earnings growing at Zenith Healthcare Limited (530665)?
How much free cash flow does Zenith Healthcare Limited (530665) generate?
Watch Zenith Healthcare Limited in the live analysis
One click puts Zenith Healthcare Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.